Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;69(4):391-395.
doi: 10.5173/ceju.2016.859. Epub 2016 Nov 30.

A prospective, randomized trial comparing the use of KTP (GreenLight) laser versus electroresection-supplemented laser in the treatment of benign prostatic hyperplasia

Cezary Torz  1 , Sławomir Poletajew  1 , Piotr Radziszewski  1
Affiliations

A prospective, randomized trial comparing the use of KTP (GreenLight) laser versus electroresection-supplemented laser in the treatment of benign prostatic hyperplasia

Cezary Torz et al. Cent European J Urol. 2016.

Abstract

Introduction: Photoselective laser vaporization of the prostate (PVP) is one of the most popular techniques of treatment of benign prostatic hyperplasia (BPH). The aim of this study was to assess the risk of thermal damage to the external urethral sphincter during PVP at distal part of prostatic urethra.

Material and methods: 66 men submitted to PVP with 80-W Green Light Laser were randomly assigned to receive standard PVP only (group A) or PVP in proximal part followed by transurethral resection in distal part of prostatic urethra (group B). Primary end-points of the study assessed at baseline, 24 hours and 8 weeks after the surgery were: urinary continence, urinary flow (Qmax), post void urine retention (PVR), international prostate symptom score (IPSS), quality of life (QoL).

Results: Per protocol analysis was eventually performed in 60 patients. Study groups did not differ in age, preoperative continence, values of Qmax, PVR, IPSS, QoL, or the rate of complete urinary retention (p >0.05). During the 8-week follow-up no patient reported urinary incontinence, while decrease in IPSS (16.3 vs. 14.9, p >0.05), QoL improvement (4.7 vs. 4.7, p >0.05), increase in Qmax (18.2 vs. 17.4, p >0.05) were similar in both study groups. Patients assigned to group B were more likely to have bleeding complications (85.2% vs. 18.2%), including patients requiring transfusion (14.8% vs. 0%). Moreover, postoperative catheterization time was shorter in group A (29.1 hrs vs. 37.2 hrs, p = 0.04).

Conclusions: Laser vaporization for treatment of BPH is safe and effective, with no significant effect on the risk of urinary incontinence in comparison to traditional methods.

Keywords: BPH; GreenLight laser; benign prostatic hyperplasia; laser therapy; vaporization of the prostate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Comment in

  • Lasers and the prostate.
    Buntrock S. Buntrock S. Cent European J Urol. 2016;69(4):396. doi: 10.5173/ceju.2016.939. Epub 2016 Nov 30. Cent European J Urol. 2016. PMID: 28151541 Free PMC article. No abstract available.

References

    1. Mebust W, Holtgrewe H, Cockett A, Peters P. Transurethral prostatectomy: Immediate and postoperative complications: cooperative study of 13 participating institutions evaluating 3885 patients. J Urol. 1989;141:243–247. - PubMed
    1. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy in living canines and in human panine cadavers. Urology. 1997;49:703–708. - PubMed
    1. Lipiński M, Jeromin M, Jeromin L. Fotoselektywna waporyzacja wysokoenergetycznym laserem KTP – nowa metoda leczenia łagodnego rozrostu stercza. Urol Pol. 2004;4:62–65.
    1. Bachmann A, Rusztat B. The KTP (greenlight) laser - principles and experiences. Minim Invasive Ther Allied Technol. 2007;16:5–10. - PubMed
    1. de la Rosette J, Collins E, Bachmann A, Woo HH. Historical aspects of laser therapy for Benign Prostatic Hyperplasia. Eur Urol Suppl. 2008;7:363–369.

LinkOut - more resources